Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Daxor Corporation before investing.

In this article, we go over a few key elements for understanding Daxor Corporation’s stock price such as:

• Daxor Corporation’s current stock price and volume
• Why Daxor Corporation’s stock price changed recently
• Upgrades and downgrades for DXR from analysts
• DXR’s stock price momentum as measured by its relative strength

About Daxor Corporation (DXR)

Before we jump into Daxor Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Want to learn more about Daxor Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Daxor Corporation.

Daxor Corporation’s Stock Price as of Market Close

As of July 31, 2026, 1:56 PM, CST, Daxor Corporation’s stock price was $10.500.

Daxor Corporation is down 0.28% from its previous closing price of $10.530.

During the last market session, Daxor Corporation’s stock traded between $10.500 and $10.500. Currently, there are approximately 5.06 million shares outstanding for Daxor Corporation.

Daxor Corporation’s price-earnings (P/E) ratio is currently at 5.8, which is low compared to the Health Care Equipment & Supplies industry median of 30.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Daxor Corporation Stock Price History

Daxor Corporation’s (DXR) price is currently up 1.99% so far this month.

During the month of July, Daxor Corporation’s stock price has reached a high of $11.970 and a low of $0.000.

Over the last year, Daxor Corporation has hit prices as high as $14.758 and as low as $8.560. Year to date, Daxor Corporation’s stock is down 28.81%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Daxor Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there were analysts who downgraded Daxor Corporation’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Daxor Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Daxor Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Daxor Corporation’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Daxor Corporation (DXR) by visiting AAII Stock Evaluator.

Relative Price Strength of Daxor Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Daxor Corporation has a weighted four-quarter relative price strength of 0.59%, which translates to a Momentum Score of 54 and is considered to be Average.

Want to learn more about how Daxor Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Daxor Corporation Stock Price: Bottom Line

As of July 31, 2026, Daxor Corporation’s stock price is $10.500, which is down 0.28% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Daxor Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.